Cocrystal Pharma, Inc. — Investor Relations & Filings
Filings indexed
534
across all filing types
Latest filing
2026-05-27
Proxy Solicitation & In…
Country
US
United States of America
Listing
US
COCP
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company that discovers and develops novel antiviral therapeutics for serious and chronic viral diseases. The company utilizes proprietary structure-based drug design technologies to create antiviral drugs that target the viral replication process. Its development pipeline includes programs targeting influenza, SARS-CoV-2 (COVID-19), norovirus, and hepatitis C. Key candidates in its pipeline include CC-42344, a PB2 inhibitor for influenza A in Phase 2 clinical trials, and CDI-988, an oral pan-viral protease inhibitor for norovirus and coronaviruses that has entered Phase 1 trials.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| DEFA14A | 2026-05-27 | English | |
| DEF 14A | 2026-05-27 | English | |
| 8-K | 2026-05-26 | English | |
| 10-Q | 2026-05-15 | English | |
| S-3 - Cocrystal Pharma, Inc. (0001412486) (Filer) | 2026-04-23 | English | |
| 8-K - Cocrystal Pharma, Inc. (0001412486) (Filer) | 2026-04-02 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47846036 | DEFA14A | 2026-05-27 | English | ||
| 47845034 | DEF 14A | 2026-05-27 | English | ||
| 47061907 | 8-K | 2026-05-26 | English | ||
| 46354503 | 10-Q | 2026-05-15 | English | ||
| 35885674 | S-3 - Cocrystal Pharma, Inc. (0001412486) (Filer) | 2026-04-23 | English | ||
| 33155750 | 8-K - Cocrystal Pharma, Inc. (0001412486) (Filer) | 2026-04-02 | English | ||
| 33115154 | 10-K - Cocrystal Pharma, Inc. (0001412486) (Filer) | 2026-03-31 | English | ||
| 33115084 | 8-K - Cocrystal Pharma, Inc. (0001412486) (Filer) | 2026-03-31 | English | ||
| 32891539 | 4 - COCRYSTAL PHARMA, INC. (0001412486) (Filer) | 2026-02-25 | English | ||
| 32891540 | 8-K - COCRYSTAL PHARMA, INC. (0001412486) (Filer) | 2026-02-19 | English | ||
| 29570660 | 4 Filing | 2026-02-09 | English | ||
| 29572690 | 8-K Filing | 2026-01-15 | English | ||
| 29572746 | 4 Filing | 2026-01-13 | English | ||
| 29572687 | 4 Filing | 2026-01-13 | English | ||
| 29572441 | 4 Filing | 2026-01-13 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Clene Inc.
A clinical-stage biopharma developing nanotherapeutics for …
|
CLNN | US | Manufacturing |
|
CLINUVEL PHARMACEUTICALS LIMITED
Develops melanocortin treatments for severe genetic, metabo…
|
CUV | AU | Manufacturing |
|
Cloudbreak Pharma Inc.
Clinical-stage ophthalmology biotech developing novel treat…
|
2592 | HK | Manufacturing |
|
Clover Biopharmaceuticals, Ltd.
Biotech developing innovative vaccines and biologics using …
|
2197 | HK | Manufacturing |
|
CMG Pharmaceutical Co., Ltd.
A pharmaceutical firm specializing in Oral Thin Film drug d…
|
058820 | KR | Manufacturing |
|
CNS Pharmaceuticals, Inc.
Develops anti-cancer drug candidates for cancers of the bra…
|
CNSP | US | Manufacturing |
|
Cobequid Life Sciences Inc.
Develops and produces vaccines for disease prevention in th…
|
— | CA | Manufacturing |
|
Co-Diagnostics, Inc.
A molecular diagnostics company that develops and markets a…
|
CODX | US | Manufacturing |
|
co.don AG
Develops autologous cell therapies for regenerative treatme…
|
CNW | DE | Manufacturing |
|
Coeptis Therapeutics Holdings, Inc.
Biopharmaceutical company developing cell therapy platforms…
|
COEP | US | Manufacturing |
Cocrystal Pharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35066/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35066 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35066 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35066 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35066}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Cocrystal Pharma, Inc. (id: 35066)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.